Big Pharma Split Corp.
TSX:PRM.TO
13.15 (CAD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Assets: | |||||||
Current Assets: | |||||||
Cash & Cash Equivalents
| 0.204 | 0.819 | 1.43 | 0.231 | 0.536 | 0.417 | 1.846 |
Short Term Investments
| 25.535 | 23.728 | 35.318 | 22.403 | 26.332 | 33.144 | 30.178 |
Cash and Short Term Investments
| 0.204 | 0.819 | 1.43 | 0.231 | 26.868 | 33.561 | 32.024 |
Net Receivables
| 0.077 | 14.004 | 0.103 | 0.104 | 0.073 | 0.07 | 0.016 |
Inventory
| -0.718 | -0.545 | -0.964 | -0.194 | 0 | 0 | 0 |
Other Current Assets
| 0.718 | 0.545 | 0.964 | 0.194 | 0.236 | 0 | 0.448 |
Total Current Assets
| 0.281 | 14.823 | 1.532 | 0.335 | 27.177 | 33.631 | 32.487 |
Non-Current Assets: | |||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 26.253 | 24.273 | 36.131 | 22.446 | 26.332 | 33.144 | 30.626 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| -26.253 | -24.273 | -36.131 | -22.446 | -26.332 | -33.144 | -30.626 |
Total Non-Current Assets
| 26.253 | 24.273 | 36.131 | 22.446 | 26.332 | 33.144 | 30.626 |
Total Assets
| 26.535 | 39.096 | 37.814 | 22.933 | 27.177 | 33.631 | 32.487 |
Liabilities & Equity: | |||||||
Current Liabilities: | |||||||
Account Payables
| 0.249 | 0.348 | 0.339 | 0.213 | 0.241 | 0.306 | 0.21 |
Short Term Debt
| 10.297 | 9.854 | 14.863 | 9.348 | 10.582 | 13.409 | 13.6 |
Tax Payables
| 0 | 0 | 0 | 0.151 | 0 | 0 | 0 |
Deferred Revenue
| -10.049 | -9.507 | -14.524 | -9.134 | 0 | -13.409 | -13.6 |
Other Current Liabilities
| -10.546 | -10.202 | -15.202 | -9.712 | 0.044 | 1.073 | 0 |
Total Current Liabilities
| 0.249 | 0.348 | 0.339 | 0.213 | 10.867 | 14.788 | 13.811 |
Non-Current Liabilities: | |||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 10.684 | 0.348 | 15.411 | 9.747 | 10.867 | 0.306 | 0.21 |
Total Liabilities
| 0.249 | 19.365 | 0.339 | 0.213 | 10.867 | 14.788 | 13.811 |
Equity: | |||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 15.851 | 19.731 | 22.404 | 13.185 | 16.309 | 18.843 | 18.677 |
Retained Earnings
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Equity
| 15.851 | 19.731 | 22.404 | 13.185 | 16.309 | 18.843 | 18.677 |
Total Equity
| 15.851 | 19.731 | 22.404 | 13.185 | 16.309 | 18.843 | 18.677 |
Total Liabilities & Shareholders Equity
| 26.535 | 39.096 | 37.814 | 22.933 | 27.177 | 33.631 | 32.487 |